• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Chrysalis Ventures

  • Portfolio
  • Investment Strategy
  • About Chrysalis
  • Team
  • News
  • Contact

Chrysalis News

meQuilibrium Enhances Digital Resilience Platform with Series of Modules to Improve Sleep, Work Performance and More

December 19, 2017

meQuilibrium, the leading provider of workplace resilience solutions, today announced a series of enhancements to its meQ Engage product, cementing the company’s position as the leader with the most data-driven and comprehensive cognitive behavioral based digital solutions platform. The company’s flagship product, meQ Engage, now applies advanced analytics that prescribe individual solutions at scale using machine learning and artificial intelligence (AI). The product currently delivers a highly individualized, yet accessible-to-everyone experience leveraging over 500 assets to help employees learn to be more resilient, spanning learning, assessment and practice tools across 63 tracks and modules. The newest modules focus on …

Continue »

Intervention Insights announces first precision medicine platform to resolve the complexities of molecular testing for cancer care

December 7, 2017

WALTHAM, Mass., Dec. 7, 2017 /PRNewswire/ -- Intervention Insights is pleased to announce the availability of Trapelo, a true advancement in the use of molecular science and targeted therapies for cancer patients. The first-of-its-kind, decision support, order management and results reporting solution for molecular testing enables real-time alignment among oncologists, labs and payors in the dynamic and increasingly complex world of precision medicine. To learn more about how Trapelo supports oncologists and their practices, visit interventioninsights.com. The team at Intervention Insights, a company dedicated to putting cancer patients first, heard oncologists asking for better lab order intelligence, more actionable test …

Continue »

Connecture Announces Brian Lindstrom as New Chief Financial Officer

December 4, 2017

BROOKFIELD, Wis., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Connecture, Inc. (OTCQX:CNXR), a provider of web-based information systems used to create health insurance marketplaces, today announced that Brian Lindstrom will join their team as Chief Financial Officer (CFO). This is part of a planned transition of Vince Estrada, who will be taking a new role within Connecture as EVP of Corporate Development, effective December 4, 2017. Brian joins Connecture from Datica Health, where he served as Chief Operating Officer. During his tenure, Brian oversaw financial, administrative, and services teams, helping to double recurring revenue year over year. Prior to this, he held roles as Chief Financial Officer and Controller at Influence Health …

Continue »

  • « Previous Page
  • Page 1
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • …
  • Page 84
  • Next Page »

Primary Sidebar

Recent News

  • Chrysalis Closes Third Exit in Nine Months
  • meQuilibrium Named to the 2019 Inc. 5000 List of America’s Fastest-Growing Private Companies
  • Experian acquires MyHealthDirect
  • Former CNN digital boss KC Estenson is running GoNoodle, an educational video company
  • StraighterLine and Dallas County Community College District (DCCCD) Launch New Partnership through the Department of Education’s EQUIP Pilot Initiative

News

Chrysalis Ventures News

Portfolio News

Newsletters

Have an investment opportunity?

Chrysalis Ventures is actively seeking opportunities to partner with talented teams to grow businesses. We look forward to hearing from you.

CONTACT US

About Chrysalis Ventures

Headquartered in Louisville, KY, Chrysalis Ventures seeks to partner with management teams across Mid-America to build businesses with enduring value through technology and active collaboration. Chrysalis manages over $400 million and has invested in more than 70 companies during its 25-year history.

(502) 583-7644
 

101 South Fifth Street,
Suite 1650
Louisville, KY 40202
Directions